Cancer
-
BusinessLilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
BusinessCelgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
-
PodcastCaesium chloride
A compound found in mineral water that is also used in medical treatments and solar cells
-
NewsEuropean chemicals body links titanium dioxide to cancer
Chemical found in everything from paint to toothpaste added to list of suspected carcinogens over inhalation risk
-
BusinessFirst biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
BusinessSeattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
BusinessJ&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
NewsEx-Harvard postdoc sues university for drug royalties
Former Harvard chemist says he lost out on millions after the technology he worked on was licensed to Merck & Co
-
NewsAction on white asbestos blocked by top exporters
Chrysotile will not be added to Rotterdam Convention’s list of hazardous substances
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
